0001104659-24-008420.txt : 20240130
0001104659-24-008420.hdr.sgml : 20240130
20240130204124
ACCESSION NUMBER: 0001104659-24-008420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240126
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Mahony John Mark
CENTRAL INDEX KEY: 0001808556
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 24580329
MAIL ADDRESS:
STREET 1: C/O LEAP THERAPEUTICS, INC.
STREET 2: 47 THORNDIKE STREET, SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm244628-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-26
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001808556
O'Mahony John Mark
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET, SUITE B1-1
CAMBRIDGE
MA
02141
0
1
0
0
Chief Manufacturing Officer
0
Common Stock
2024-01-26
4
M
0
5000
A
5000
D
Restricted Stock Units
2024-01-26
4
M
0
5000
0
D
Common Stock
5000
0
D
Restricted Stock Units convert into common stock on a one-for-one basis.
The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.
On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
2024-01-30